Immunotherapy for Glioblastoma: Current State, Challenges, and Future Perspectives

Glioblastoma is the most lethal intracranial primary malignancy by no optimal treatment option. Cancer immunotherapy has achieved remarkable survival benefits against various advanced tumors, such as melanoma and non-small-cell lung cancer, thus triggering great interest as a new therapeutic strateg...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Minfeng, Oh, In Young, Mahanty, Arpan, Jin, Wei-Lin, Yoo, Jung Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565291/
https://www.ncbi.nlm.nih.gov/pubmed/32824974
http://dx.doi.org/10.3390/cancers12092334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565291/
https://www.ncbi.nlm.nih.gov/pubmed/32824974
http://dx.doi.org/10.3390/cancers12092334

Ejemplares similares